Pentoxifylline for intermittent claudication
Obliterating atherosclerosis of the lower extremities leading to a decrease in blood flow occurs in approximately 12% of the population. The pathology is most commonly manifested at the stage of intermittent claudication. The pain occurs only as long as a specific physical activity is undertaken. In...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2015-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/153 |
id |
doaj-b806e448b5b6477fb2779a947e41a19d |
---|---|
record_format |
Article |
spelling |
doaj-b806e448b5b6477fb2779a947e41a19d2021-07-28T13:29:20ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902015-12-0104525710.21518/2079-701X-2015-4-52-57153Pentoxifylline for intermittent claudicationN. A. Vaulin0City Hospital №29, MoscowObliterating atherosclerosis of the lower extremities leading to a decrease in blood flow occurs in approximately 12% of the population. The pathology is most commonly manifested at the stage of intermittent claudication. The pain occurs only as long as a specific physical activity is undertaken. Intermittent claudication is registered in 6,4-15,5 per 1 000 people over 55 years old. The article describes the basic principles of treatment and evaluates the efficacy of pentoxifylline.https://www.med-sovet.pro/jour/article/view/153облитерирующий атеросклероз сосудов нижних конечностейперемежающая хромотапентоксифиллинвазонитobliterating atherosclerosis of the lower extremitiesintermittent claudicationpentoxifyllinevasonit |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
N. A. Vaulin |
spellingShingle |
N. A. Vaulin Pentoxifylline for intermittent claudication Медицинский совет облитерирующий атеросклероз сосудов нижних конечностей перемежающая хромота пентоксифиллин вазонит obliterating atherosclerosis of the lower extremities intermittent claudication pentoxifylline vasonit |
author_facet |
N. A. Vaulin |
author_sort |
N. A. Vaulin |
title |
Pentoxifylline for intermittent claudication |
title_short |
Pentoxifylline for intermittent claudication |
title_full |
Pentoxifylline for intermittent claudication |
title_fullStr |
Pentoxifylline for intermittent claudication |
title_full_unstemmed |
Pentoxifylline for intermittent claudication |
title_sort |
pentoxifylline for intermittent claudication |
publisher |
Remedium Group LLC |
series |
Медицинский совет |
issn |
2079-701X 2658-5790 |
publishDate |
2015-12-01 |
description |
Obliterating atherosclerosis of the lower extremities leading to a decrease in blood flow occurs in approximately 12% of the population. The pathology is most commonly manifested at the stage of intermittent claudication. The pain occurs only as long as a specific physical activity is undertaken. Intermittent claudication is registered in 6,4-15,5 per 1 000 people over 55 years old. The article describes the basic principles of treatment and evaluates the efficacy of pentoxifylline. |
topic |
облитерирующий атеросклероз сосудов нижних конечностей перемежающая хромота пентоксифиллин вазонит obliterating atherosclerosis of the lower extremities intermittent claudication pentoxifylline vasonit |
url |
https://www.med-sovet.pro/jour/article/view/153 |
work_keys_str_mv |
AT navaulin pentoxifyllineforintermittentclaudication |
_version_ |
1721274524132966400 |